BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, May 10, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 1, 2004
View Archived Issues
Shionogi researchers claim iNOS inhibitors and their therapeutic use
Read More
New leucomycin A7 derivatives and their use in Gram-positive bacterial infections
Read More
Abbott presents new PDE4 and TNF-alpha production inhibitors
Read More
Novel MCH antagonists in early development at Aventis
Read More
Novel glycogen phosphorylase inhibitors developed by Aventis team
Read More
New vanilloid VR1 antagonists and their use in pain, urinary incontinence, etc.
Read More
New beta-lactamase-resistant carbapenems discovered at Sankyo
Read More
Pyrazole-based antiplatelet agents newly developed at Daiichi
Read More
Selective inhibitors of PKB/Akt designed at Astex
Read More
ABP-309: a second-generation VEGFR tyrosine kinase inhibitor with a promising preclinical profile
Read More
First clinical results reported for AMG-706 in patients with advanced tumors
Read More
Inhibition of SOD1 via copper depletion results in inhibition of angiogenesis
Read More
Novel VEGFR2/PDGFR kinase inhibitor with antitumor and antiangiogenic activity presented by Bayer
Read More
Pharmacyclics identifies potential development candidate from a series of sapphyrin derivatives
Read More
Recordati to market prulifloxacin in Spain
Read More
Millennium submits supplemental NDA for Velcade
Read More
Bayer inlicenses Seattle Genetics' ADC technology
Read More
New approvals for Enbrel
Read More
L-BLP-25 liposome vaccine receives fast track status for NSCLC
Read More
Phase I cleared to begin for CDA-1 for C. difficile associated diarrhea
Read More
Genaera receives SBIR grant for development of trodusquemine
Read More
New phase II study for M-40403 in cancer pain
Read More
Enrollment completed in phase IIb African sleeping sickness trial of DB-289
Read More
New dosing option of Omnicef approved for pediatric use
Read More
Expanded phase II trial for squalamine opens enrollment
Read More
Epimmune plans phase II study of EP-2101 cancer vaccine
Read More
Exelixis to acquire X-Ceptor Therapeutics
Read More
Merck voluntarily withdraws Vioxx
Read More
New data on the efficacy of onercept in active Crohn's disease
Read More
Update on the efficacy of ABT-874 in active Crohn's disease
Read More
Prous Science launches new enhanced version of LifeSciChannel.com
Read More
Uriach selects UR-14048 for further development for parenteral treatment of acute pain
Read More
NP-031112 and NP-00111 demonstrate neuroprotectant effects
Read More